2021 Medicines for Europe-IGBA conference speakers assert that off-patent medicines will be crucial to rebuild healthcare post-COVID-19.
List view / Grid view
This whitepaper outlines the important components of an environmental monitoring programme, providing practical advice and best practice guidance.
All-in-one Drug Anti-Counterfeit Solution for improved pharma product security and brand protection, brought to big pharma companies via tec5USA.
In this article, EPR's Hannah Balfour outlines six factors that could significantly challenge the generics and biosimilars market in the next decade.
With 16 reactors at 1mL, The Crystal16 enables scientists to determine solubility curves, assess dispersion stability and critical solution temperatures.
Grow X-ray quality crystals to make ensure you aren’t losing useful chemical information. Access diverse crystallisation methods with the CrystalBreeder!
Automating your solid-state screening process enables you to perform the crystallisation experiments with just a small amount of effort.
In this whitepaper, C2C’s Product & Process Development Lead explains how using digital modelling in the design process can guarantee results.
Learn how you can go about changing QC test methods and how this can go a long way to helping your lab achieve data integrity compliance.
The first interchangeable biosimilar insulin product will help increase access and affordability of insulin for diabetics.
Learn here how to identify polymorphic transformation by using Raman and the Crystalline instrument.